Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF for preventing neutropenia in breast cancer
NCT02805205Phase 4Completed
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- Apr 2013
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of pegfilgrastim in neutropenia, sponsored by CSPC Baike Biopharmaceutical. Started Apr 2013; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02805205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805205.